The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives
Open accessAbstract
Circulating adiponectin concentrations are reduced in obese individuals, and this reduction has been proposed to have a crucial role in the pathogenesis of atherosclerosis and cardiovascular diseases associated with obesity and the metabolic syndrome. We focus on the effects of adiponectin on glucose and lipid metabolism and on the molecular anti-atherosclerotic properties of adiponectin and also discuss the factors that increase the circulating levels of adiponectin. Adiponectin reduces inflammatory cytokines and oxidative stress, which leads to an improvement of insulin resistance. Adiponectin-induced improvement of insulin resistance and adiponectin itself reduce hepatic glucose production and increase the utilization of glucose and fatty acids by skeletal muscles, lowering blood glucose levels. Adiponectin has also β cell protective effects and may prevent the development of diabetes. Adiponectin concentration has been found to be correlated with lipoprotein metabolism; especially, it is associated with the metabolism of high-density lipoprotein (HDL) and triglyceride (TG). Adiponectin appears to increase HDL and decrease TG. Adiponectin increases ATP-binding cassette transporter A1 and lipoprotein lipase (LPL) and decreases hepatic lipase, which may elevate HDL. Increased LPL mass/activity and very low density lipoprotein (VLDL) receptor and reduced apo-CIII may increase VLDL catabolism and result in the reduction of serum TG. Further, adiponectin has various molecular anti-atherosclerotic properties, such as reduction of scavenger receptors in macrophages and increase of cholesterol efflux. These findings suggest that high levels of circulating adiponectin can protect against atherosclerosis. Weight loss, exercise, nutritional factors, anti-diabetic drugs, lipid-lowering drugs, and anti-hypertensive drugs have been associated with an increase of serum adiponectin level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176 · cited 1×
“Adiponectin receptors include two similar transmembrane receptors which are known as AdipoR1 and AdipoR2, and another type of receptor without a transmembrane domain which may act as a co-receptor for the high-molecular weight (HMW) form of adiponectin on endothelial and smooth muscle cells [6,7].”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170 · cited 1×
“01% of all plasma proteins (5–10 μg/mL), and its plasma concentration was reported to be higher in women than in men [9,10].”
BackgroundNovel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041591798 · Cited by 1,985
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“Adiponectin prevents ceramide- or inflammatory cytokine-induced apoptosis in cultured β cells [35,36] and maintains β cell mass and glucose homeostasis in ob/ob mice and in a mice model of type 1 diabetes [35,37].”
BackgroundYokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., et al. (2000) · Blood · doi:10.1182/blood.v96.5.1723 · Cited by 1,297
Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1057 · Cited by 1,277
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Achari, A., & Jain, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061321 · Cited by 1,158
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., & Scherer, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207198200 · Cited by 1,086
Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes
Waki, H., Yamauchi, T., Kamon, J., Ito, Y., Uchida, S., Kita, S., Hara, K., Hada, Y., Vasseur, F., Froguel, P., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300365200 · Cited by 981
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., & Rossetti, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14120 · Cited by 935
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Adiponectin as an anti-inflammatory factor
Ouchi, N., & Walsh, K. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.026 · Cited by 872
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin
Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T.-S., & Lodish, H. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403382101 · Cited by 859
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes
Wolf, A. M., Wolf, D., Rumpold, H., Enrich, B., & Tilg, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.145 · Cited by 819
Role of Adiponectin in Preventing Vascular Stenosis
Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206083200 · Cited by 811
Freeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 728
Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000018622.84402.ff · Cited by 695
Insulin signaling pathways in time and space
Saltiel, A. R., & Pessin, J. E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02207-3 · Cited by 628
MATSUZAWA, Y., FUNAHASHI, T., & NAKAMURA, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07793.x · Cited by 597
Association of Hypoadiponectinemia With Impaired Vasoreactivity
Ouchi, N., Ohishi, M., Kihara, S., Funahashi, T., Nakamura, T., Nagaretani, H., Kumada, M., Ohashi, K., Okamoto, Y., Nishizawa, H., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000083488.67550.b8 · Cited by 590
An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls
Okamoto, Y., Arita, Y., Nishida, M., Muraguchi, M., Ouchi, N., Takahashi, M., Igura, T., Inui, Y., Kihara, S., Nakamura, T., et al. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978586 · Cited by 568
Combs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1068 · Cited by 545
The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly
Barzilay, J. I., Abraham, L., Heckbert, S. R., Cushman, M., Kuller, L. H., Resnick, H. E., & Tracy, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2384 · Cited by 545
Macro‐ and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Shi, Y., & Vanhoutte, P. M. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12521 · Cited by 545
Decreased Plasma Adiponectin Concentrations in Women with Dyslipidemia
Matsubara, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2764 · Cited by 544
YAMAMOTO, Y., HIROSE, H., SAITO, I., TOMITA, M., TANIYAMA, M., MATSUBARA, K., OKAZAKI, Y., ISHII, T., NISHIKAI, K., & SARUTA, T. (2002) · Clinical Science · doi:10.1042/cs1030137 · Cited by 490
Liu, C., Feng, X., Li, Q., Wang, Y., Li, Q., & Hua, M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.028 · Cited by 470
Wu, X., Motoshima, H., Mahadev, K., Stalker, T. J., Scalia, R., & Goldstein, B. J. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1355 · Cited by 463
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T. A., Lopez, B. L., Koch, W., Chan, L., Goldstein, B. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.666941 · Cited by 453
Shetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S., & Veves, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2450 · Cited by 415
Wang, Y., Lam, K. S. L., Xu, J. Y., Lu, G., Xu, L. Y., Cooper, G. J. S., & Xu, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501149200 · Cited by 380
Role of Adipocytokines on the Pathogenesis of Atherosclerosis in Visceral Obesity.
FUNAHASHI, T., NAKAMURA, T., SHIMOMURA, I., MAEDA, K., KURIYAMA, H., TAKAHASHI, M., ARITA, Y., KIHARA, S., & MATSUZAWA, Y. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.202 · Cited by 380
Mirza, S., Hossain, M., Mathews, C., Martinez, P., Pino, P., Gay, J. L., Rentfro, A., McCormick, J. B., & Fisher-Hoch, S. P. (2012) · Cytokine · doi:10.1016/j.cyto.2011.09.029 · Cited by 358
Hypoadiponectinemia Is Closely Linked to Endothelial Dysfunction in Man
Shimabukuro, M., Higa, N., Asahi, T., Oshiro, Y., Takasu, N., Tagawa, T., Ueda, S., Shimomura, I., Funahashi, T., & Matsuzawa, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021883 · Cited by 347
Ceddia, R. B., Somwar, R., Maida, A., Fang, X., Bikopoulos, G., & Sweeney, G. (2005) · Diabetologia · doi:10.1007/s00125-004-1609-y · Cited by 345
Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505649200 · Cited by 326
Guha, M., Bai, W., Nadler, J. L., & Natarajan, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.23.17728 · Cited by 309
Morohoshi, M., Fujisawa, K., Uchimuraa, I., & Numano, F. (1996) · Diabetes · doi:10.2337/diab.45.7.954 · Cited by 281
Yoshida, H., Yanai, H., Ito, K., Tomono, Y., Koikeda, T., Tsukahara, H., & Tada, N. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.012 · Cited by 269
Self-citationGarvey, W. T., Van Gaal, L., Leiter, L. A., Vijapurkar, U., List, J., Cuddihy, R., Ren, J., & Davies, M. J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.002 · Cited by 261
Adiponectin Inhibits Endothelial Synthesis of Interleukin-8
Kobashi, C., Urakaze, M., Kishida, M., Kibayashi, E., Kobayashi, H., Kihara, S., Funahashi, T., Takata, M., Temaru, R., Sato, A., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000194328.57164.36 · Cited by 255
Ouedraogo, R., Wu, X., Xu, S.-Q., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R., & Goldstein, B. J. (2006) · Diabetes · doi:10.2337/db05-1174 · Cited by 250
Shklyaev, S., Aslanidi, G., Tennant, M., Prima, V., Kohlbrenner, E., Kroutov, V., Campbell-Thompson, M., Crawford, J., Shek, E. W., Scarpace, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2333912100 · Cited by 247
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Hogan, A. E., Gaoatswe, G., Lynch, L., Corrigan, M. A., Woods, C., O’Connell, J., & O’Shea, D. (2014) · Diabetologia · doi:10.1007/s00125-013-3145-0 · Cited by 239
Potential Anti-Atherosclerotic Properties of Astaxanthin
Kishimoto, Y., Yoshida, H., & Kondo, K. (2016) · Marine Drugs · doi:10.3390/md14020035 · Cited by 221
Self-citationWang, C., Mao, X., Wang, L., Liu, M., Wetzel, M. D., Guan, K.-L., Dong, L. Q., & Liu, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700098200 · Cited by 210
Inflammation and the Incidence of Type 2 Diabetes
Bertoni, A. G., Burke, G. L., Owusu, J. A., Carnethon, M. R., Vaidya, D., Barr, R. G., Jenny, N. S., Ouyang, P., & Rotter, J. I. (2010) · Diabetes Care · doi:10.2337/dc09-1679 · Cited by 197
Matsuda, M., & Shimomura, I. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9271-7 · Cited by 196
Hayashi, T., Fukui, T., Nakanishi, N., Yamamoto, S., Tomoyasu, M., Osamura, A., Ohara, M., Yamamoto, T., Ito, Y., & Hirano, T. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0491-5 · Cited by 196
Adipokines and Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Lowe, G. D. O., Rumley, A., Cherry, L., Whincup, P. H., & Sattar, N. (2007) · Diabetes Care · doi:10.2337/dc06-2416 · Cited by 194
Chruściel, P., Sahebkar, A., Rembek-Wieliczko, M., Serban, M.-C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., Mosteoru, S., Blaha, M. J., Martin, S. S., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.897 · Cited by 194
García-Hermoso, A., Ramírez-Vélez, R., Ramírez-Campillo, R., Peterson, M. D., & Martínez-Vizcaíno, V. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096605 · Cited by 194
Resveratrol and diabetes: A critical review of clinical studies
Öztürk, E., Arslan, A. K. K., Yerer, M. B., & Bishayee, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.070 · Cited by 184
Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
Qiao, L., Zou, C., van der Westhuyzen, D. R., & Shao, J. (2008) · Diabetes · doi:10.2337/db07-0435 · Cited by 183
Sirico, F., Bianco, A., D'Alicandro, G., Castaldo, C., Montagnani, S., Spera, R., Di Meglio, F., & Nurzynska, D. (2018) · Childhood Obesity · doi:10.1089/chi.2017.0269 · Cited by 182
Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., & Eckel, J. (2004) · Diabetologia · doi:10.1007/s00125-003-1293-3 · Cited by 180
Miller, R. A., Chu, Q., Le Lay, J., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., & Birnbaum, M. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45942 · Cited by 179
Early Atherosclerosis in Obese Juveniles Is Associated with Low Serum Levels of Adiponectin
Pilz, S., Horejsi, R., Möller, R., Almer, G., Scharnagl, H., Stojakovic, T., Dimitrova, R., Weihrauch, G., Borkenstein, M., Maerz, W., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0167 · Cited by 179
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: Arandomized clinical trial
Frøssing, S., Nylander, M., Chabanova, E., Frystyk, J., Holst, J. J., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13053 · Cited by 178 · cited 6×
“The GLP-1 receptor agonist liraglutide did not change adiponectin levels in women with PCOS [158].”
BackgroundInfluentialAdiponectin signaling in the liver
Combs, T. P., & Marliss, E. B. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9280-6 · Cited by 173
Tao, C., Sifuentes, A. J., & Holland, W. L. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.003 · Cited by 164
Matsuura, F., Oku, H., Koseki, M., Sandoval, J. C., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Masuda, D., Maeda, N., Tsujii, K., Ishigami, M., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.040 · Cited by 163
Atherogenic dyslipidemia and oxidative stress: a new look
Rizzo, M., Kotur‐Stevuljević, J., Berneis, K. K., Spinas, G. A., Rini, G. B., Jelić‐Ivanović, Z., Spasojević‐Kalimanovska, V., & Vekić, J. (2009) · Translational research · doi:10.1016/j.trsl.2009.01.008 · Cited by 162
Vascular endothelium dysfunction: a conservative target in metabolic disorders
Jamwal, S., & Sharma, S. (2018) · Inflammation Research · doi:10.1007/s00011-018-1129-8 · Cited by 159
Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia
von Eynatten, M., Schneider, J. G., Humpert, P. M., Rudofsky, G., Schmidt, N., Barosch, P., Hamann, A., Morcos, M., Kreuzer, J., Bierhaus, A., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2925 · Cited by 157
Adiponectin and lipoprotein metabolism
Christou, G. A., & Kiortsis, D. N. (2013) · Obesity Reviews · doi:10.1111/obr.12064 · Cited by 147
Postprandial Hyperlipidemia and Remnant Lipoproteins
Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145
Tobita, H., Sato, S., Miyake, T., Ishihara, S., & Kinoshita, Y. (2017) · Current Therapeutic Research · doi:10.1016/j.curtheres.2017.07.002 · Cited by 142
Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo
Schneider, J. G., von Eynatten, M., Schiekofer, S., Nawroth, P. P., & Dugi, K. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2181 · Cited by 141
Adiponectin as a potential biomarker of vascular disease
Mohammadi, S., Arefhosseini, S. R., Ebrahimi‐Mameghani, M., Fallah, P., & Bazi, Z. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s48753 · Cited by 140
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
Tsubakio‐Yamamoto, K., Matsuura, F., Koseki, M., Oku, H., Sandoval, J. C., Inagaki, M., Nakatani, K., Nakaoka, H., Kawase, R., Yuasa‐Kawase, M., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.009 · Cited by 139
Staiger, H., Kaltenbach, S., Staiger, K., Stefan, N., Fritsche, A., Guirguis, A., Péterfi, C., Weisser, M., Machicao, F. E., Stümvoll, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2195 · Cited by 132
Kazumi, T., Kawaguchi, A., Hirano, T., & Yoshino, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.008 · Cited by 124
Mousa, A., Naderpoor, N., Teede, H. J., Scragg, R. K. R., & de Courten, B. V. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nux077 · Cited by 122
Yu, N., Ruan, Y., Gao, X., & Sun, J. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0042-121605 · Cited by 120
Marques-Vidal, P. M., Schmid, R., Bochud, M., Bastardot, F., von Känel, R., Paccaud, F. M., Glaus, J., Preisig, M., Waeber, G., & Vollenweider, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051768 · Cited by 116
Pοlyzos, S. A., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.013 · Cited by 115
Adipocytokines and VLDL Metabolism
Ng, T. W., Watts, G. F., Farvid, M. S., Chan, D. C., & Barrett, P. H. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.795 · Cited by 110
Chan, D. C., Watts, G. F., Ng, T. W., Uchida, Y., Sakai, N., Yamashita, S., & Barrett, P. H. R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045120 · Cited by 108
Yang, K., Zeng, L., Bao, T., & Ge, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0346-x · Cited by 103
Adiponectin deficiency suppresses ABCA1 expression and ApoA‐I synthesis in the liver
Oku, H., Matsuura, F., Koseki, M., Sandoval, J. C., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Masuda, D., Maeda, N., Ohama, T., Ishigami, M., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.038 · Cited by 97
The Role of Insulin Receptor Substrate-1 Gene (IRS1) in Type 2 Diabetes in Pima Indians
Kovacs, P. L., Hanson, R. L., Lee, Y., Yang, X., Kobes, S., Permana, P. A., Bogardus, C., & Baier, L. J. (2003) · Diabetes · doi:10.2337/diabetes.52.12.3005 · Cited by 96
Thorand, B., Zierer, A., Baumert, J. J., Meisinger, C., Herder, C., & Köenig, W. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03043.x · Cited by 91
Impact of HDL on adipose tissue metabolism and adiponectin expression
Linthout, S. V., Foryst‐Ludwig, A., Spillmann, F., Peng, J., Feng, Y., Meloni, M., Craeyveld, E. V., Kintscher, U., Schultheiß, H., Geest, B. D., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.001 · Cited by 91
Exercise, adipokines and pediatric obesity: a meta-analysis of randomized controlled trials
García‐Hermoso, A., Ceballos-Ceballos, R., Poblete-Aro, C., Hackney, A. C., Mota, J. A. P. S., & Ramírez‐Vélez, R. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.230 · Cited by 91
Kantartzis, K., Rittig, K., Balletshofer, B. M., Machann, J., Schick, F., Porubská, K., Fritsche, A., Häring, H., & Stefan, N. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.067397 · Cited by 90
Effects of Mixed Carotenoids on Adipokines and Abdominal Adiposity in Children: A Pilot Study
Canas, J. A., Lochrie, A. S., McGowan, A. G., Hossain, J., Schettino, C., & Balagopal, P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00185 · Cited by 89
Sugiyama, S., Jinnouchi, H., Kurinami, N., Hieshima, K., Yoshida, A., Jinnouchi, K., Nishimura, H., Suzuki, T., MIYAMOTO, F., Kajiwara, K., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0701-17 · Cited by 88
Danielsson, A., Öst, A., Lystedt, E., Kjølhede, P., Gustavsson, J., Nyström, F. H., & Strålfors, P. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04396.x · Cited by 85
Vincent, H. K., Bourguignon, C. M., WELTMAN, A. L., Vincent, K. R., Barrett, E. J., Innes, K. E., & Taylor, A. G. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.022 · Cited by 85
Wu, J. H. Y., Cahill, L. E., & Mozaffarian, D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3899 · Cited by 83
Dinca, M., Șerban, M.-C., Sahebkar, A., Mikhailidis, D. P., Toth, P. P., Martin, S. S., Blaha, M. J., Blüher, M., Gurban, C., Penson, P. E., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.035 · Cited by 83
Li, Y.-F., Chang, Y.-Y., Huang, H.-C., Wu, Y.-C., Yang, M.-D., & Chao, P.-M. (2015) · Nutrition · doi:10.1016/j.nut.2014.11.008 · Cited by 81
Adipokines and Incident Type 2 Diabetes in an Aboriginal Canadian Population
Ley, S. H., Harris, S. B., Connelly, P. W., Mamakeesick, M., Gittelsohn, J., Hegele, R. A., Retnakaran, R. R., Zinman, B., & Hanley, A. J. (2008) · Diabetes Care · doi:10.2337/dc08-0036 · Cited by 79
Zhang, P., Wang, Y., Fan, Y., Tang, Z., & Wang, N. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178061 · Cited by 78
Regulation of hormone-sensitive lipase in streptozotocin-induced diabetic rats
Sztalryd, C., & Kraemer, F. B. (1995) · Metabolism · doi:10.1016/0026-0495(95)90135-3 · Cited by 76
Zhang, M., Chen, P., Chen, S., Sun, Q., Qc, Z., Jy, C., Yx, L., Xh, C., Ren, M., & Wang, J.-K. (2014) · PubMed · Cited by 76
Antioxidant Supplementation Lowers Exercise‐Induced Oxidative Stress in Young Overweight Adults
Vincent, H. K., Bourguignon, C. M., Vincent, K. R., WELTMAN, A. L., Bryant, M., & Taylor, A. G. (2006) · Obesity · doi:10.1038/oby.2006.261 · Cited by 75
Chan, D. C., Barrett, P. H. R., Ooi, E. M. M., Ji, J., Chan, D. T., & Watts, G. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1457 · Cited by 73
Wang, J., Lin, S.-D., Lee, W., Su, S., Lee, I., Tu, S., Tseng, Y., Lin, S., & Sheu, W. H. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.014 · Cited by 69
Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults
Im, J., Kim, S.-H., Lee, J., Shim, J., Lee, H.-R., & Lee, D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.027 · Cited by 68
Wang, M., Wang, D., Zhang, Y., Wang, X., Liu, Y., & Xia, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.017 · Cited by 66
Suzuki, D., Toyoda, M., Kimura, M., Miyauchi, M., Yamamoto, N., Sato, H., Tanaka, E., Kuriyama, Y., Miyatake, H., Abe, M., et al. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.8961 · Cited by 61
Okamoto, A., Yokokawa, H., Sanada, H., & Naito, T. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0137-9 · Cited by 61
Impact of the high‐molecular‐weight form of adiponectin on endothelial function in healthy young men
Torigoe, M., Matsui, H., Ogawa, Y., Murakami, H., Murakami, R., Cheng, X. W., Numaguchi, Y., Murohara, T., & Okumura, K. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02876.x · Cited by 59
de Vries, R., Groen, A. K., Perton, F. G., Dallinga‐Thie, G. M., van Wijland, M. J. A., Dikkeschei, L. D., Wolffenbuttel, B. H. R., van Tol, A., & Dullaart, R. P. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.027 · Cited by 59
Kajikawa, M., Maruhashi, T., Matsumoto, T., Iwamoto, Y., Iwamoto, A., Oda, N., Kishimoto, S., Matsui, S., Aibara, Y., Hidaka, T., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.035 · Cited by 59
Suksomboon, N., Poolsup, N., & Prasit, T. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01295.x · Cited by 58
Nomoto, H., Miyoshi, H., Furumoto, T., Oba, K., Tsutsui, H., Inoue, A., Atsumi, T., Manda, N., Kurihara, Y., Aoki, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164255 · Cited by 58
Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women
Kwon, K., Jung, S. H., Choi, C., & Park, S. H. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.03.050 · Cited by 54
Yoshida, H., Ishikawa, T., 須藤, 美., Kurosawa, H., Hirowatari, Y., Ito, K., Yanai, H., Tada, N., & Suzuki, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4358 · Cited by 53
Self-citationKhosravi-Largani, M., Nojomi, M., Aghili, R., Otaghvar, H. A., Tanha, K., Seyedi, S. H. S., & Mottaghi, A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3550-z · Cited by 52
Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes
Su, J.-R., Lu, Z.-H., Su, Y., Zhao, N., Dong, C., Sun, L., Zhao, S., & Li, Y.-N. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0035-1569287 · Cited by 50
Marsche, G., Zelzer, S., Meinitzer, A., Kern, S., Meissl, S., Pregartner, G., Weghuber, D., Almer, G., & Mangge, H. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00933 · Cited by 50
Derosa, G., Maffioli, P., Ferrari, I., Mereu, R., Ragonesi, P. D., Querci, F., Franzetti, I. G., Gadaleta, G., Ciccarelli, L., Piccinni, M. N., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1255036 · Cited by 49
Ishihara, H., Yamaguchi, S., Nakao, I., Okitsu, A., & Asahina, S. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12745 · Cited by 49
Shimazu, T., Inami, N., Satoh, D., Kajiura, T., Yamada, K., Iwasaka, T., & Nomura, S. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-008-0301-3 · Cited by 46
Takagi, H., Niwa, M., Mizuno, Y., Goto, S.-N., & Umemoto, T. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.02.006 · Cited by 45
Fournier, N., Francone, O. L., Rothblat, G. H., Goudounèche, D., Cambillau, M., Kellner-Weibel, G., Robinet, P., Royer, L. J., MOATTI, N., Simon, A. C., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.011 · Cited by 44
Xiao, X., Dong, Y., Zhong, J., Cao, R., Zhao, X., Wen, G., & Liu, J. (2011) · Endocrine · doi:10.1007/s12020-011-9531-9 · Cited by 43
Sahebkar, A., & Watts, G. F. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.026 · Cited by 42
Yassine, H. N., Belopolskaya, A., Schall, C., Stump, C. S., Lau, S. S., & Reaven, P. D. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.001 · Cited by 42
Kobayashi, J., Kusunoki, M., Murase, Y., Kawashiri, M., Higashikata, T., Miwa, K., Katsuda, S., Takata, M., Asano, A., Nohara, A., et al. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870318 · Cited by 42
Okada, T., Saito, E., Kuromori, Y., Miyashita, M., Iwata, F., Hara, M., & Harada, K. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.030 · Cited by 39
Shimabukuro, M., Higa, M., Yamakawa, K., Masuzaki, H., & Sata, M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.109 · Cited by 39
Ma, Y., & Liu, D. (2013) · Gene Therapy · doi:10.1038/gt.2013.8 · Cited by 38
Iwamoto, M., Imai, K., Ohta, H., Shirouchi, B., & Sato, M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-52 · Cited by 38
Amara, N. B., Tourniaire, F., Maraninchi, M., Attia, N., Amiot, M. J., Raccah, D., Valéro, R., Landrier, J., & Darmon, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0728-6 · Cited by 37
Tsubakio‐Yamamoto, K., Sugimoto, T., Nishida, M., Okano, R., Monden, Y., Kitazume-Taneike, R., Yamashita, T., Nakaoka, H., Kawase, R., Yuasa‐Kawase, M., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.011 · Cited by 36
Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
Liu, X., Men, P., Wang, Y., Zhai, S., & Liu, C. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0372-7 · Cited by 35
Suzuki, K. A. O., Inoue, T., Hashimoto, S., Ochiai, J., Kusuhara, Y., Ito, Y., & Hamajima, N. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.05.029 · Cited by 34
Farimani, A. R., Hariri, M., Azimi–Nezhad, M., Borji, A., Zarei, S., & Hooshmand, E. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1110-6 · Cited by 34
Ohira, M., Yamaguchi, T., Saiki, A., Ban, N., Kawana, H., Nagumo, A., Murano, T., Shirai, K., & Tatsuno, I. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s65275 · Cited by 33
The Effect of Low Calorie Diet on Adiponectin Concentration: A Systematic Review and Meta-Analysis
Salehi‐Abargouei, A., Izadi, V., & Azadbakht, L. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1549878 · Cited by 33
Shi, L., Zhu, J., Yang, P., Tang, X., Yu, W., Pan, C., Shen, M., Zhu, D., Cheng, J., & Ye, X. (2017) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2017.01.003 · Cited by 33
Age and sex differences in serum adiponectin and its association with lipoprotein fractions
Tomono, Y., Hiraishi, C., & Yoshida, H. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217699233 · Cited by 32
Self-citationBahreini, M., Ramezani, A.-H., Shishehbor, F., & Mansoori, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.12.002 · Cited by 32
Nomiyama, T., Shimono, D., Horikawa, T., Fujimura, Y., Ohsako, T., Terawaki, Y., Fukuda, T., Motonaga, R., Tanabe, M., Yanase, T., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0022 · Cited by 32
Miyatani, Y., Yasui, T., Uemura, H., Yamada, M., Matsuzaki, T., Kuwahara, A., Tsuchiya, N., Yuzurihara, M., Kase, Y., & Irahara, M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31815c85ed · Cited by 31
Yokoyama, H., Kanno, S., Ishimura, I., & Node, K. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.010 · Cited by 31
Yanai, H., Katsuyama, H., Hamasaki, H., Adachi, H., Moriyama, S., Yoshikawa, R., & Sako, A. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2385w · Cited by 31
Self-citationAcarbose Treatment Increases Serum Total Adiponectin Levels in Patients with Type 2 Diabetes
Ochiai, H., Hikari, O. O. K. A., SHIDA, C., ISHIKAWA, T., Inoue, D., & Okazaki, R. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-107 · Cited by 30
Kangas‐Kontio, T., Huotari, A., Ruotsalainen, H. J., Herzig, K., Tamminen, M., Ala‐Korpela, M., Savolainen, M. J., & Kakko, S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.022 · Cited by 30
Christou, G. A., Tellis, C. C., Elisaf, M., Tselepis, A. D., & Kiortsis, D. N. (2012) · HORMONES · doi:10.14310/horm.2002.1345 · Cited by 30
Sartang, M. M., Mazloom, Z., Sohrabi, Z., Sherafatmanesh, S., & Barati‐Boldaji, R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.012 · Cited by 27
Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis
Suksomboon, N., Poolsup, N., & Ko, H. D. K. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s137571 · Cited by 27
Becic, T., & Studenik, C. R. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.2.101 · Cited by 26
Ghadge, A. A., Diwan, A. G., Harsulkar, A., & Kuvalekar, A. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.041 · Cited by 24
The Low-Dose (7.5 mg/day) Pioglitazone Therapy
Yanai, H., & Adachi, H. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3144w · Cited by 24
Self-citationTriglycerides and remnant particles as risk factors for coronary artery disease
Nakamura, T., & Kugiyama, K. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0047-3 · Cited by 23
Kong, W., Niu, X., Zeng, T., Lü, M., & Chen, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140565 · Cited by 23
Sahebkar, A. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.017 · Cited by 21
Llanos, A. A. M., Peng, J., Pennell, M. L., Krok, J. L., Vitolins, M. Z., DeGraffinreid, C. R., & Paskett, E. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3222 · Cited by 19
Shim, C. Y., Park, S., Kim, J., Shin, D. J., Ko, Y., Kang, S., Choi, D., Ha, J., Jang, Y., & Chung, N. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.3.375 · Cited by 19
Lin, C.-H., Hsieh, S., Sun, J., Tsai, J.-S., & Huang, Y. (2015) · Scientific Reports · doi:10.1038/srep16968 · Cited by 19
Clarenbach, J. J., Vega, G. L., ADAMS-HUET, B. A., Considine, R. V., Ricks, M., & Sumner, A. E. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.07001 · Cited by 18
Takagi, H., & Umemoto, T. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.071 · Cited by 18
Pfützner, A., Schöndorf, T., Tschöpe, D., Lobmann, R., Merke, J., Müller, J., Lehmann, U., Fuchs, W. A., & Forst, T. M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0233 · Cited by 18
Li, C., Zhang, J.-Y., Yu, D. M., & Zhang, Q.-M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-41 · Cited by 18
Ezenwaka, C. E., Kalloo, R., Uhlig, M., & Eckel, J. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814454 · Cited by 18
Effect of ezetimibe on plasma adipokines: a systematic review and meta‐analysis
Doleželová, E., Stein, E. A., Derosa, G., Maffioli, P., Nachtigal, P., & Sahebkar, A. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13250 · Cited by 18
Yoshida, H., Hirowatari, Y., Kurosawa, H., & Tada, N. (2005) · Clinical Science · doi:10.1042/cs20040353 · Cited by 16
Self-citationRelationship between Serum Cholesterol Efflux Capacity and Glucose Intolerance in Japanese-Americans
Kubota, M., Nakanishi, S., Hirano, M., Maeda, S., Yoneda, M., Awaya, T., Yamane, K., & Kohno, N. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24315 · Cited by 15
Sam, S., Haffner, S. M., Davidson, M. H., D’Agostino, R. B., Pérez, A., & Mazzone, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1699 · Cited by 15
Kitajima, K., Miura, S.-I., Yamauchi, T., Uehara, Y., Kiya, Y., Rye, K., Kadowaki, T., & Saku, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.131 · Cited by 14
Vanhala, M. J., Kumpula, L. S., Soininen, P., Kangas, A. J., Ala‐Korpela, M., Kautiainen, H., Mäntyselkä, P. T., & Saltevo, J. T. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1065 · Cited by 13
Vincentis, A. D., Pedone, C., Gentilucci, U. V., Picardi, A., Derosa, G., Maffioli, P., & Sahebkar, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161006122934 · Cited by 13
Forst, T. M., Weber, M. M., Löbig, M., Lehmann, U., Müller, J., Hohberg, C., Friedrich, C., Fuchs, W. A., & Pfützner, A. (2010) · Clinical Science · doi:10.1042/cs20100161 · Cited by 11
Yanai (2011) · Journal of Endocrinology and Metabolism · doi:10.4021/jem38w · Cited by 11
Lapointe, A., Tchernof, A., Lamarche, B., Piché, M., Weisnagel, J., Bergeron, J., & Lemieux, S. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.007 · Cited by 10
Yanai, H., Hamasaki, H., Adachi, H., Moriyama, S., & Hirowatari, Y. (2011) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v1i3.38 · Cited by 8
Self-citationEffects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials
Chen, W., Huang, Z., Bi, M., Xu, X., & Zhao, N. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0439-0 · Cited by 6
Cited by
The role of adipokines in health and disease
Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11051290 · Cited by 463
Liu, Y., Vu, V., & Sweeney, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00842 · Cited by 69
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Exercise as a Therapeutic Strategy for Obesity: Central and Peripheral Mechanisms
Zhang, Y., Wang, R., Liu, T., & Wang, R. (2024) · Metabolites · doi:10.3390/metabo14110589 · Cited by 27
Metadata
- Authors
- Yanai, H., & Yoshida, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-08
- Volume
- 20
- Issue
- 5
- Pages
- 1190
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2921788949
- Cited by
- 468
- References
- 192
- FWCI
- 36.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.